CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 58 enrolled
Drug / intervention
Clobetasol propionate foam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00842153
NCT00842153Phase 4Completed
CompareCT.gov

A Study to Evaluate the Efficacy and Tolerability of Clobetasol Propionate vs. Vehicle in the Treatment of Mild to Moderate Plaque-Type Psoriasis

Stiefel, a GSK Company·interventional·Posted Feb 12, 2009·Updated Oct 9, 2017

In Brief

A Phase 4 clinical trial evaluating Clobetasol propionate foam and Vehicle foam for Psoriasis. Completed, enrolled 58 participants across 2 sites.

Detailed Summary

The purpose of the study is to compare the efficacy and safety of Clobetasol propionate to that of its Vehicle in the treatment of mild to moderate plaque-type psoriasis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 12, 2009
Enrollment StartNov 1, 2007
Primary CompletionDec 1, 2007
Study CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.4 years ago

Interventions

Clobetasol propionate foamdrug

Topical Clobetasol propionate foam

Vehicle foamdrug

Vehicle foam does not include the active drug.